V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180009203 | 180002463 | null | null | null | null | 2018-02-23 | NB HRNBL-1 Isotretinoin | null | null | CABOZANTINIB | 100362738 |
| 180009302 | 180002467 | null | null | null | null | 2017-02-26 | Docetaxel 75mg/m2 (21 day) | null | null | FLUOROURACIL + OXALIPLATIN | 101022470 |
| 180009316 | 180002470 | null | null | null | null | 2022-02-19 | BUSULFAN + MELPHALAN | null | null | CYCLOPHOSPHAMIDE | 101571675 |
| 180009346 | 180002472 | null | null | null | 2016-12-12 | 2016-12-25 | CNS Headstart II Myeloablation | null | null | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100063118 |
| 180009363 | 180002473 | null | null | null | null | 2019-07-19 | LENVATINIB | null | null | CYTARABINE + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB | 101285455 |
| 180009379 | 180002474 | null | null | null | null | 2017-06-14 | CABOZANTINIB | null | null | LANREOTIDE | 101306378 |
| 180009623 | 180002486 | null | null | null | null | 2019-07-02 | Dacarbazine | null | null | CARBOPLATIN + RT | 100674591 |
| 180009703 | 180002489 | null | null | null | null | 2021-04-07 | CNS GCT II | null | null | PACLITAXEL | 101174783 |
| 180009717 | 180002490 | null | null | null | 2021-01-05 | 2021-01-06 | NB Relapsed CCLG guidelines TVD | null | null | LENVATINIB | 100715492 |
| 180009808 | 180002493 | null | null | null | null | 2018-04-20 | NB HRNBL-1 COJEC Ind COURSE B | null | null | NB HRNBL-1 ISOTRETINOIN | 100200045 |
| 180009863 | 180002497 | null | null | null | null | 2019-11-17 | LENVATINIB | null | null | GEMCITABINE | 101057542 |
| 180010009 | 180002505 | null | null | null | null | 2017-09-21 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | null | null | TEMOZOLOMIDE | 100245794 |
| 180010054 | 180002510 | 1.6 | null | null | null | 2020-10-27 | PEMBROLIZUMAB | null | null | LENVATINIB | 100847966 |
| 180010078 | 180002512 | null | null | null | null | 2019-11-28 | CETUXIMAB + IRINOTECAN + MDG | null | null | NOT MATCHED | 101074586 |
| 180010089 | 180002514 | null | null | null | null | 2017-09-09 | Docetaxel 100mg/m2 (21 day) | null | null | NB HRNBL-1 ISOTRETINOIN | 101513398 |
| 180010217 | 180002521 | null | null | null | null | 2018-08-05 | BUSULFAN + MELPHALAN | null | null | LENVATINIB | 100907593 |
| 180010221 | 180002522 | null | null | null | 2015-06-28 | 2016-08-15 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | null | null | CABOZANTINIB | 100590552 |
| 180010302 | 180002525 | 0 | null | null | null | 2017-02-07 | LENVATINIB | null | null | CYCLOPHOSPHAMIDE + VINCRISTINE | 101292168 |
| 180010313 | 180002526 | null | null | null | null | 2020-12-01 | Capecitabine | null | null | NB HRNBL-1 ISOTRETINOIN | 101528499 |
| 180010315 | 180002527 | null | null | null | null | 2016-02-05 | CABOZANTINIB | null | null | CABOZANTINIB | 100820525 |
| 180010360 | 180002531 | null | null | null | null | 2021-02-08 | Cisplatin+Doxorubicin+Etoposide 28d | null | null | LENVATINIB | 101043405 |
| 180010381 | 180002534 | null | null | null | null | 2016-04-21 | null | null | null | NB HRNBL-1 ISOTRETINOIN | 100322445 |
| 180010418 | 180002540 | null | null | null | null | 2018-12-07 | CISPLATIN + DOX + ETOPOSIDE + MITOTANE | null | null | TRIAL UNSPECIFIED | 101627569 |
| 180010500 | 180002545 | null | null | null | null | 2014-06-12 | NB HRNBL-1 Isotretinoin | null | null | CAPECITABINE + LOMUSTINE | 100481092 |
| 180010572 | 180002550 | null | null | null | null | 2020-01-31 | NB HRNBL-1 BUMEL MAT | null | null | LENVATINIB | 101806533 |
| 180010672 | 180002558 | 1.78 | null | null | null | 2018-06-03 | IRINOTECAN + MDG | null | null | CAPECITABINE + OXALIPLATIN | 100230100 |
| 180010681 | 180002559 | null | null | null | 2017-05-13 | 2017-10-28 | NB HRNBL-1 Isotretinoin | null | null | NOT MATCHED | 100384680 |
| 180010694 | 180002560 | null | null | null | null | 2022-03-18 | Brentuximab | null | null | TEMOZOLOMIDE | 100172820 |
| 180010740 | 180002562 | 1.69 | null | null | null | 2017-11-03 | CETUXIMAB + IRINOTECAN + MDG | null | null | DINUTUXIMAB BETA | 101126015 |
| 180010760 | 180002563 | null | null | null | 2021-06-28 | 2021-12-27 | null | null | null | LENVATINIB | 101721845 |
| 180010793 | 180002566 | null | null | null | null | 2020-03-17 | Escalated BEACOPP | null | null | ABIRATERONE | 101782443 |
| 180010829 | 180002567 | 1.83 | null | null | null | 2014-05-15 | Trial Unspecified | null | null | CABOZANTINIB | 101536229 |
| 180010910 | 180002573 | null | null | null | null | 2017-03-29 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | PEMETREXED | 100897667 |
| 180011201 | 180002589 | null | null | null | null | 2021-09-14 | NB Rel CCLG guidelines Irin & Temoz | null | null | CAPECITABINE + LOMUSTINE | 101353882 |
| 180011264 | 180002592 | null | null | null | null | 2019-08-09 | ETOPOSIDE | null | null | LENVATINIB | 100172193 |
| 180011465 | 180002601 | null | null | null | null | 2016-08-10 | CISPLATIN + DOXORUBICIN + ETOPOSIDE | null | null | NB HRNBL-1 ISOTRETINOIN | 101417709 |
| 180011471 | 180002602 | null | null | null | null | 2016-07-12 | NB Rel CCLG guidelines Irin & Temoz | null | null | NOT MATCHED | 101802180 |
| 180011509 | 180002604 | null | null | null | null | 2016-08-23 | Mitotane 3 - 3.5g | null | null | NB HRNBL-1 ISOTRETINOIN | 101057392 |
| 180011518 | 180002605 | null | null | null | null | 2017-05-10 | null | null | null | CAPECITABINE + OXALIPLATIN | 100122156 |
| 180011605 | 180002608 | null | null | null | null | 2019-07-16 | LENVATINIB | null | null | LENVATINIB | 101044554 |
| 180011624 | 180002609 | null | null | null | null | 2017-12-19 | NB HRNBL-1 BUMEL MAT | null | null | NB HRNBL-1 ISOTRETINOIN | 100402036 |
| 180011803 | 180002616 | null | null | null | null | 2016-03-02 | NB HRNBL-1 COJEC Ind COURSE C | null | null | NB HRNBL-1 ISOTRETINOIN | 100777758 |
| 180011867 | 180002620 | null | null | null | 2020-02-04 | 2020-02-08 | NB relapse Temozolamide/ topotecan | null | null | TEMOZOLOMIDE | 100835866 |
| 180011949 | 180002623 | null | null | null | 2019-03-30 | 2019-08-15 | Carboplatin + Liposomal Doxorubicin | null | null | CNS MEDBL HR CISPLATIN/VINCRISTINE/CYCLOPHOSPHAMIDE | 101805505 |
| 180011970 | 180002625 | null | null | null | 2016-08-22 | 2017-06-19 | NB Rel CCLG guidelines Irin & Temoz | null | null | TEMOZOLOMIDE | 100885217 |
| 180012028 | 180002629 | null | null | null | null | 2017-07-29 | Trial Unspecified | null | null | NB HRNBL-1 ISOTRETINOIN | 101510187 |
| 180012044 | 180002630 | null | null | null | null | 2016-07-12 | null | null | null | LENVATINIB | 101061997 |
| 180012131 | 180002640 | null | null | null | null | 2017-10-12 | BLEOMYCIN | null | null | CABOZANTINIB | 101686645 |
| 180012160 | 180002644 | null | null | null | null | 2020-01-12 | null | null | null | CISPLATIN | 101544286 |
| 180012205 | 180002647 | null | null | null | null | 2019-06-11 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE | 100400920 |